RhoVac AB (under name change to Chosa Oncology AB) has completed the acquisition of Chosa ApS and a new board and CEO have taken office

Regulatory press release: RhoVac AB (under name change to Chosa Oncology AB) (“RhoVac or the “Company) has today completed the acquisition of the Danish privately owned oncology company Chosa ApS (“Chosa). As a result, a new...[Read more]